Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32975569.
- Also identified by DOI 10.1001/jamanetworkopen.2020.17517 and PMC identifier 7519417.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.
Medical subject headings
- Adenocarcinoma, Mucinous
- Antineoplastic Agents
- Carcinoma, Endometrioid
- Carcinoma, Ovarian Epithelial
- Chemotherapy, Adjuvant
- Cytoreduction Surgical Procedures
- Neoadjuvant Therapy
- Ovarian Neoplasms